WHO chief scientist disappointed by CureVac trial

  • 3 years   ago
WHO chief scientist disappointed by CureVac trial

The World Health Organization's chief scientist said on Friday that results from the CureVac COVID-19 vaccine's initial trial were disappointing.

German biotech firm CureVac' (5CV.DE) vaccine proved only 47% effective in an initial trial read-out. 

"It was disappointing to see the results from CureVac," the WHO's Soumya Swaminathan told a news conference.

Comments